Ziprasidone is marketed under the trade name Geodon [1]. It is also known by the trade name Zeldox in some regions [2].
What is Geodon used for?
Geodon, the trade name for ziprasidone, is an atypical antipsychotic medication used to treat schizophrenia and bipolar disorder [1][2]. Specifically, it is prescribed for manic or mixed episodes associated with bipolar I disorder in adults and children aged 10 and older [1]. It is also used to manage acute agitation in patients with schizophrenia [2].
When does the patent for Geodon expire?
The patent landscape for ziprasidone, and thus its branded forms like Geodon, is complex due to multiple patents covering different aspects of the drug, including its composition, manufacturing, and formulations [3]. Information on specific patent expiry dates for Geodon is available through resources like DrugPatentWatch.com [3]. These patents determine when generic versions can legally enter the market.
How does ziprasidone compare to other antipsychotics?
Ziprasidone is classified as an atypical antipsychotic, a group that includes medications such as risperidone, olanzapine, quetiapine, and aripiprazole [4]. Atypical antipsychotics generally work by affecting dopamine and serotonin receptors in the brain [4]. They are often prescribed when first-line treatments have not been effective or to manage specific symptoms [4].
Who manufactures Geodon?
Geodon was originally developed and marketed by Pfizer [5]. Following patent expirations, generic versions of ziprasidone are now available from various pharmaceutical manufacturers [6].